Report error Found 52 Enz. Inhib. hit(s) with all data for entry = 7356
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 5.90nM ΔG°: -47.0kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 6.60nM ΔG°: -46.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 8.90nM ΔG°: -46.0kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 10.3nM ΔG°: -45.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 12nM ΔG°: -45.2kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 12.1nM ΔG°: -45.2kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 15.2nM ΔG°: -44.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 16.5nM ΔG°: -44.4kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 32.4nM ΔG°: -42.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 40.4nM ΔG°: -42.2kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 41.5nM ΔG°: -42.1kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 47.9nM ΔG°: -41.8kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 51.6nM ΔG°: -41.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 52nM ΔG°: -41.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 68.4nM ΔG°: -40.9kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 72.2nM ΔG°: -40.8kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 72.7nM ΔG°: -40.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 78.8nM ΔG°: -40.5kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 82.6nM ΔG°: -40.4kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 83.2nM ΔG°: -40.4kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 86.8nM ΔG°: -40.3kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 110nM ΔG°: -39.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 114nM ΔG°: -39.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 140nM ΔG°: -39.1kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 160nM ΔG°: -38.8kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 200nM ΔG°: -38.2kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 210nM ΔG°: -38.1kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 230nM ΔG°: -37.9kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 236nM ΔG°: -37.8kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 315nM ΔG°: -37.1kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 350nM ΔG°: -36.8kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 470nM ΔG°: -36.1kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 500nM ΔG°: -36.0kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 560nM ΔG°: -35.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 760nM ΔG°: -34.9kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 930nM ΔG°: -34.4kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 1.26E+3nM ΔG°: -33.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A3 [I248L](Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 1.53E+3nM ΔG°: -33.2kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 1.91E+3nM ΔG°: -32.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 2.45E+3nM ΔG°: -32.0kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 2.72E+3nM ΔG°: -31.8kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 3.02E+3nM ΔG°: -31.5kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 3.14E+3nM ΔG°: -31.4kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A1(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 3.58E+3nM ΔG°: -31.1kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 3.70E+3nM ΔG°: -31.0kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 3.70E+3nM ΔG°: -31.0kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 3.93E+3nM ΔG°: -30.9kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 3.95E+3nM ΔG°: -30.8kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 4.08E+3nM ΔG°: -30.8kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
The United States of America, As Represented By The Secretary, Department of Health and Human Services
US Patent
Affinity DataKi: 4.41E+3nM ΔG°: -30.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
